Valneva SE (INRLF)
OTCMKTS · Delayed Price · Currency is USD
4.770
+0.520 (12.24%)
Sep 15, 2025, 9:30 AM EDT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $772.00 million as of September 16, 2025. Its market cap has increased by 59.88% in one year.
Market Cap
772.00M
Enterprise Value
813.89M
Revenue
230.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.77
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 133.86M to 772.00M, an increase of 476.71%. That is a compound annual growth rate of 10.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 772.00M | 112.38% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | 862.29M | 228.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |